Organ preservation for advanced resectable cancer of the base of tongue and hypopharynx: a Southwest Oncology Group Trial.
about
(125)I Seed Permanent Implantation as a Palliative Treatment for Stage III and IV Hypopharyngeal CarcinomaSequential induction chemotherapy followed by radical chemo-radiation in the treatment of locoregionally advanced head-and-neck cancer.Diffusion magnetic resonance imaging: an imaging treatment response biomarker to chemoradiotherapy in a mouse model of squamous cell cancer of the head and neckTransoral laser microsurgery (TLM) +/- adjuvant therapy for advanced stage oropharyngeal cancer: outcomes and prognostic factors.Long-term results of intensity-modulated radiotherapy concomitant with chemotherapy for hypopharyngeal carcinoma aimed at laryngeal preservationTransoral laser microsurgery as primary treatment for advanced-stage oropharyngeal cancer: a United States multicenter study.Efficacy of induction selection chemotherapy vs primary surgery for patients with advanced oral cavity carcinoma.Concurrent radiochemotherapy in advanced hypopharyngeal cancerTreatment results for hypopharyngeal cancer by different treatment strategies and its secondary primary--an experience in Taiwan.A single centre experience with sequential and concomitant chemoradiotherapy in locally advanced stage IV tonsillar cancerClinical utility of multimodality imaging with dynamic contrast-enhanced MRI, diffusion-weighted MRI, and 18F-FDG PET/CT for the prediction of neck control in oropharyngeal or hypopharyngeal squamous cell carcinoma treated with chemoradiation.Dynamic contrast-enhanced MR imaging predicts local control in oropharyngeal or hypopharyngeal squamous cell carcinoma treated with chemoradiotherapy.Chemoradiation for advanced hypopharyngeal carcinoma: a retrospective study on efficacy, morbidity and quality of life.Transoral robotic surgery and transoral laser microsurgery for oropharyngeal squamous cell cancer.Induction chemotherapy in the management of squamous cell carcinoma of the head and neck.Function and organ preservation in adult cancers of the head and neck.Treatment response assessment of head and neck cancers on CT using computerized volume analysisAnalysis of feasibility and toxicity of concurrent chemoradiotherapy with S-1 for locally advanced squamous cell carcinoma of the head and neck in elderly cases and/or cases with comorbidity.A phase 2 trial of induction nab-paclitaxel and cetuximab given with cisplatin and 5-fluorouracil followed by concurrent cisplatin and radiation for locally advanced squamous cell carcinoma of the head and neck.Chemoselection as a strategy for organ preservation in advanced oropharynx cancer: response and survival positively associated with HPV16 copy number.Treatment of head and neck cancers: issues for clinical pharmacists.Heterogeneous impact of alcohol consumption according to treatment method on survival in head and neck cancer: A prospective study.The role of sequential chemoradiation for local advanced oropharyngeal carcinoma.Utility of weekly docetaxel combined with preoperative radiotherapy for locally advanced esophageal cancer from pathological analysis.Using low-dose radiation to potentiate the effect of induction chemotherapy in head and neck cancer: Results of a prospective phase 2 trial.Dynamic contrast-enhanced MRI, diffusion-weighted MRI and 18F-FDG PET/CT for the prediction of survival in oropharyngeal or hypopharyngeal squamous cell carcinoma treated with chemoradiation.Selective organ preservation in operable locally advanced head and neck squamous cell carcinomas guided by primary site restaging biopsy: long-term results of two sequential brown university oncology group chemoradiotherapy studies.Functional organ preservation after chemoradiotherapy in elderly patients with loco-regionally advanced head and neck squamous cell carcinoma.Gemcitabine-based induction chemotherapy and concurrent with radiation in advanced head and neck cancer.Concurrent chemoradiotherapy with cisplatin and fluorouracil for locally advanced hypopharyngeal carcinoma.Outcomes utilizing intensity-modulated radiotherapy in oropharyngeal cancers: Tonsils versus base of tongue.Predictive value of 1H MR spectroscopy and 18F-FDG PET/CT for local control of advanced oropharyngeal and hypopharyngeal squamous cell carcinoma receiving chemoradiotherapy: a prospective study.Imaging strategy for response evaluation to chemoradiotherapy of the nodal disease in patients with head and neck squamous cell carcinoma.Different clinical outcomes between locally advanced hypopharyngeal and oropharyngeal cancer treated with definitive concurrent chemoradiotherapy: implication for subgroup selection for induction chemotherapy.Predictive markers, including total lesion glycolysis, for the response of lymph node(s) metastasis from head and neck squamous cell carcinoma treated by chemoradiotherapy.PET/CT and 3-T whole-body MRI in the detection of malignancy in treated oropharyngeal and hypopharyngeal carcinoma.Concurrent chemoradiotherapy with cisplatin, 5-fluorouracil, methotrexate, and leucovorin in patients with advanced resectable squamous cell carcinoma of the larynx and hypopharynx
P2860
Q26738657-29C8A938-E06F-4605-97C0-6631942D02F4Q33380006-818EB019-A96A-45A1-8FD5-05C1101334C5Q33388183-76E4F7E0-1D3C-4575-96C7-D9E9C790A0A6Q33477468-721C77AF-DFC9-4B7F-9132-31ED95D49F55Q33542810-FEEBFBB4-9ED4-4BD6-9EF5-3DF1376812CCQ33809636-0EFBCA96-3FF1-44C1-80B4-B8AC359A3186Q33918767-F183998C-FB48-447E-9B18-33E8A0B9D64DQ33931220-5B032FBB-8644-421C-AA66-A813DFEE49DBQ34221226-DB36AB5A-6F9A-4955-A9EC-2CAF2F8F17B0Q34498577-6F2A5BF3-E4DE-4E55-91C7-0C2F7A2A1BECQ34757933-BCB5E785-F857-4587-917D-606844BDB968Q34951384-B98423F8-4D82-4310-A96C-3C90789FF02DQ35745561-95EE7EA7-3578-4583-8166-BE265B621902Q35965635-30C40EB0-60D8-4418-9429-2686E70F15F4Q36613979-45849C95-AC49-43A3-93F3-7AAE1A7C1975Q36752044-335C27C5-2C77-4AAE-9E9F-9A2957C9835FQ37157066-76D24086-B745-4FDD-B3B3-D17672237BA8Q37308769-0CE44423-E999-45CE-AC2A-8449EA98ABA5Q37322374-44A63F78-DD55-4136-9DB2-97C74413DA33Q37342399-852E74ED-2502-4EDA-8396-474C38FD11BDQ37461437-67C65087-AC72-49A0-92A9-0147CCC0DF81Q37611653-04DC52A2-E45A-4698-9C3C-3CDB674CA90BQ38030880-FEFA4E18-33A3-4F90-B885-0CA4EC60A0D5Q38122414-76885521-626B-4C08-8FC2-EA0D0D740047Q40121235-9C02F65C-4785-40A7-9106-9F7F8C7B14ACQ40890024-4303E4BC-91C4-4859-9DE7-CDC83AD5EE78Q43842326-0C47BA16-FD79-44DE-BC81-CC64B5213805Q44792291-8D4F4475-73FB-4F10-8D9E-D4B8735D8DD7Q44808667-F820A845-25DA-4881-97CF-F808A6BEB82AQ46637472-2F45A7E6-9ACE-4C23-AAAF-BB83A20124D2Q48133084-05C7C8B9-EB9B-4C6C-886D-36C7BE99382AQ49569229-21FA9341-6027-46BA-B054-E7B4AE016472Q50898009-E4F16C58-732C-45C4-B034-83D5220ACFDEQ52903066-3A691455-CDF8-4154-8860-18C8998616C5Q52924821-6EAD9A71-EC13-40E6-9BEE-880DFE1118FEQ53243977-53B5A6AF-C09E-4372-BBF5-AD56E93A3BD6Q58080590-0BEEDD12-B400-48DD-B7BF-A880D90A9D38
P2860
Organ preservation for advanced resectable cancer of the base of tongue and hypopharynx: a Southwest Oncology Group Trial.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
Organ preservation for advance ...... outhwest Oncology Group Trial.
@en
type
label
Organ preservation for advance ...... outhwest Oncology Group Trial.
@en
prefLabel
Organ preservation for advance ...... outhwest Oncology Group Trial.
@en
P2093
P356
P1476
Organ preservation for advance ...... outhwest Oncology Group Trial.
@en
P2093
David E Schuller
David J Adelstein
Ehab Hanna
George H Yoo
James Moon
John F Ensley
Michael Leblanc
P G Shankar Giri
Susan G Urba
P356
10.1200/JCO.2005.04.017
P407
P577
2005-01-01T00:00:00Z